{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:30:56Z","timestamp":1765279856912},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Lars Hiertas Memorial Foundation","award":["F2011-0409"],"award-info":[{"award-number":["F2011-0409"]}]},{"name":"Selanders Memorial Foundation"}],"content-domain":{"domain":["jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jns.2014.07.040","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T15:00:41Z","timestamp":1406386841000},"page":"184-188","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies"],"prefix":"10.1016","volume":"345","author":[{"given":"Kristin","family":"Elf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Askmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingela","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rostedt","family":"Punga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2014.07.040_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2014.07.040_bb0010","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/j.nmd.2012.10.014","article-title":"Fatigue in immune-mediated neuropathies","volume":"22","author":"Merkies","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jns.2014.07.040_bb0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain\u2013Barre syndrome","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2014.07.040_bb0020","first-page":"136","article-title":"Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?","volume":"12","author":"Prietl","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jns.2014.07.040_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S0029665111001650","article-title":"Vitamin D and immune function: an overview","volume":"71","author":"Hewison","year":"2012","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jns.2014.07.040_bb0030","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2014.07.040_bb0035","doi-asserted-by":"crossref","first-page":"e20433","DOI":"10.1371\/journal.pone.0020433","article-title":"Low vitamin D in narcolepsy with cataplexy","volume":"6","author":"Carlander","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2014.07.040_bb0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/annrheumdis-2012-201849","article-title":"Low serum levels of vitamin D in idiopathic inflammatory myopathies","volume":"72","author":"Azali","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2014.07.040_bb0045","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2014.07.040_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1464-5491.2011.03379.x","article-title":"Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001\u20132004 NHANES","volume":"29","author":"Soderstrom","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jns.2014.07.040_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","article-title":"Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogren's syndrome","volume":"39","author":"Agmon-Levin","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jns.2014.07.040_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2014.07.040_bb0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2014.07.040_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2014.07.040_bb0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2014.07.040_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.autrev.2007.07.001","article-title":"Vitamin D in rheumatoid arthritis","volume":"7","author":"Cutolo","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jns.2014.07.040_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0b013e31820af93d","article-title":"Sun exposure and vitamin D are independent risk factors for CNS demyelination","volume":"76","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2014.07.040_bb0090","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/ard.2010.148494","article-title":"Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus","volume":"70","author":"Ritterhouse","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jns.2014.07.040_bb0095","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2014.07.040_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2011.04.015","article-title":"Vitamin D metabolism and innate immunity","volume":"347","author":"Lagishetty","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jns.2014.07.040_bb0105","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2014.07.040_bb0110","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jns.2014.07.040_bb0115","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2014.07.040_bb0120","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.0801543","article-title":"Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response","volume":"182","author":"Tang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2014.07.040_bb0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.107.127209","article-title":"Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1\/Th17 to a Th2 and regulatory T cell profile","volume":"324","author":"Daniel","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jns.2014.07.040_bb0130","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.081242","article-title":"Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults","volume":"24","author":"Bischoff-Ferrari","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jns.2014.07.040_bb0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/07315724.2003.10719287","article-title":"Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D","volume":"22","author":"Heaney","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jns.2014.07.040_bb0140","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1001\/jama.294.18.2336","article-title":"Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake","volume":"294","author":"Steingrimsdottir","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2014.07.040_bb0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1474-4422(13)70036-X","article-title":"Controversies and priorities in amyotrophic lateral sclerosis","volume":"12","author":"Turner","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2014.07.040_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000117447","article-title":"Hypovitaminosis D and decreased bone mineral density in amyotrophic lateral sclerosis","volume":"37","author":"Sato","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2014.07.040_bb0155","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","article-title":"Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis","volume":"20","author":"Karam","year":"2013","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jns.2014.07.040_bb0160","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0140-6736(89)91124-0","article-title":"Age, vitamin D, and solar ultraviolet","volume":"2","author":"Holick","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2014.07.040_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-6606-6-16","article-title":"Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms","volume":"6","author":"Long","year":"2013","journal-title":"Mol Brain"},{"key":"10.1016\/j.jns.2014.07.040_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0b013e31825fdf01","article-title":"Vitamin D and disease activity in multiple sclerosis before and during interferon-beta treatment","volume":"79","author":"Loken-Amsrud","year":"2012","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14004869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X14004869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T09:54:10Z","timestamp":1538387650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X14004869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022510X14004869"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.040","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2014.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}